Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

ReproNovo ApS

Denmark Amagerfaelledvej 106, 2300 Copenhagen, Denmark

About the sponsor

ReproNovo ApS focuses on clinical research in assisted reproduction, with particular attention to women undergoing in vitro fertilisation and intracytoplasmic sperm injection. The funded studies are centred on reproductive tract function and treatment-related outcomes relevant to fertility care.

  • IVF and ICSI patient populations
  • Uterine contractility
  • Reproductive pharmacology

Clinical activity in this area reflects interest in therapies intended to support reproductive procedures and improve understanding of uterine response in fertility settings.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments

Recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Sponsor:ReproNovo ApS

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).